Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue
+6.50%
EPS
−129.4%
Free cash flow
+135.6%
Total debt
−2.31%

Quarter to August 2026, against a year earlier

11.72 0.04 +0.34%
Market cap
$2.6B
P/E
0.0×
Fwd P/E
−93.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a

Neogen Corporation (NEOG) Free cash flow

Alert me on Free cash flow

Neogen Corporation's free cash flow for fiscal 2026 was $32.0M, compared with −$41.3M in fiscal 2025. Over the twelve months to 31 August 2026 it was $49.9M. Over the past ten years it has ranged from −$76.0M (fiscal 2024) to $61.8M (fiscal 2020); the current reading is higher than 42% of that period. Neogen Corporation ranks 30th of 149 Medical Devices companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2026 $32.0M —
FY2025 −$41.3M —
FY2024 −$76.0M —
FY2023 −$23.9M —
FY2022 $43.6M (19.80%)
FY2021 $54.4M (12.05%)
FY2020 $61.8M 25.71%
FY2019 $49.2M 2.07%
FY2018 $48.2M 5.45%
FY2017 $45.7M 116.48%

Quarterly newest first

Period Free cash flow Change
Aug 2026 $4.7M (82.06%)
May 2026 $26.2M 134.54%
Feb 2026 $11.2M 42.69%
Nov 2025 $7.8M —
43 more quarters

Against its own ten years

Low −$76.0M High $61.8M
Ten-year median $38.9M
Current reading's percentile 42

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on NEOG